SOPHiA GENETICS SA Ordinary Shares (SOPH) Stock
NASDAQ · SOPH
8.24
Fundamentals
Market cap
$697.20M
Price / Earnings ratio
-8.6x
Price / Sales ratio
8.1x
Price / Book ratio
8.4x
Return on assets
-0.5%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About SOPHiA GENETICS SA Ordinary Shares
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
SectorHealthcare
IndustryHealth Information Services
Employees415
CEOMr. Ross Jordan Muken B.Sc.
IPO DateJul 21, 2021
HeadquartersRolle, Switzerland
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder & Executive Chairman | 1978 |
| Mr. Ross Jordan Muken B.Sc. | CEO & Director | 1980 |
| Mr. George A. Cardoza M.B.A. | Executive VP & CFO | 1962 |
| Mr. Abhimanyu Verma | EVP & Chief Technology Officer | — |
| Dr. Zhenyu Xu Ph.D. | Executive VP & Chief Scientific Officer | 1983 |
| Kellen Sanger | Head of Strategy and Investor Relations | — |
| Mr. Daan van Well L.L.M., M.B.A. | Executive VP and Chief Legal & Compliance Officer | 1975 |
| Mr. Kevin Puylaert | SVP & Chief Sales Officer | — |
| Ms. Manuela Da Silva Valente B.A. | Executive VP & Chief People Officer | 1971 |
| Dr. Philippe Menu M.B.A., M.D., Ph.D. | Executive VP, Chief Medical Officer & Chief Product Officer | 1982 |
Fundamentals
Valuation
Market cap$697.20M
Price-to-sales ratio8.09
Price-to-book value8.39
Price-earnings ratio-8.60
Return on Equity-141.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-1.15
Income Statement
Average volume701,634
EBITDA$-64.13M
1 year high (52w)$8.98
1 year low (52w)$3.21
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



